Conference Overview

The Global Clinical Trials Connect 2023 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.

 

The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.

 

This conference intends to focus on the global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.

This program will certainly educate health care scientists on trial design, operations, organizing trials, research computing, regulatory aspects, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention, diagnosis, clinical trial-related ethics and disease treatments.

 

The summit will facilitate an invaluable networking opportunities with decision makers and focus on real case studies, insightful presentations and round tables.

 

It gives us a great pleasure in welcoming you to the Global Clinical Trials Connect 2023.

 


KEY HIGHLIGHTS

  • Patient Recruitment and Site selection
  • Innovative trial designs
  • Partnership & Collaboration - Sponsors, CROs, Sites and External Vendors
  • Patient centric clinical trials
  • Making Patient Engagement a Reality
  • New innovations in Patient Recruitment planning and execution on a clinical trial
  • Outsourcing strategies and models
  • Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome
  • Streamlined IRT development process
  • Pharmacovigilance & Clinical Trials
  • Post-Clinical Trial closed communities
  • How to future proof your clinical operations
  • Diversity and Inclusion in Clinical Trials
  • Implementing Risk Based Monitoring
  • Streamlining R&D and lower costs in clinical trials
  • Adaptive Trial Model
  • Clinical Trial Auditing
  • Real World Clinical Trial Strategies
  • Data Quality & Technology
  • Clinical Data Strategy & Analytics
  • Electronic Data Capture (EDC) Systems
  • Decentralised Clinical Trials
  • Clinical Technology and Driving Innovation
  • M-Health, Wearable and Consumer Technology
  • Big-Data, IoT and Artificial Intelligence in Clinical trials
  • Blockchain technology for improving clinical research quality

 


WHO SHOULD ATTEND THE CONFERENCE

 

This event is designed for senior level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution provider and Government institutions.

 

Attendees includes VPs, GMs, Directors, Heads and Managers of

  • Clinical Trials
  • Clinical Study Management
  • Clinical Operations
  • Clinical Research
  • Patient Organizations
  • Patient Recruitment
  • Outsourcing
  • Vendor Management
  • Site Management
  • Site Monitoring
  • Clinical Pharmacology
  • Clinical Data Management
  • Risk Monitoring
  • EDC
  • Clinical/Digital Innovation
  • Clinical Design/Protocol design/ Strategy makers
  • Clinical Research Sites
  • CROs and CMOs
  • Hospitals/ Associations
  • Regulatory affairs 

 

 

 

 

pharmaceutical companies

Speakers

VIEW ALL

There are plenty of opportunities to position yourself as a thought leader & showcase your company.

For enquiries on speaker opportunities please e-mail to speaker@corvusglobalevents.com

Become a Speaker


Wednesday - 10th May 2023

  • 08:00
  • Registration & Refreshments

  • 08:50
  • Chairperson’s opening remarks


    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

  • 09:00
  • Strategies for globalization in clinical trials

    • Connecting the developed and the developing nations
    • Dealing with differences owing to culture and ethnicity
    • Role of CROs and third party stakeholders

    Francis Crawley

    Francis Crawley Executive Director
    Good Clinical Practice Alliance - Europe (GCPA)

  • 09:30
  • Stepping up the decentralization of clinical trials


    Michael Zaiac

    Michael Zaiac Head of Medical Affairs Oncology Region Europe
    Novartis

  • 10:00
  • Innovative trial designs to save time and cost without compromising on the efficiency

    • Strategies & Methods for flexible design trials
    • The Adoption and Impact of Adaptive Trial Designs
    • Preclinical environment and trial designs Opportunities and Limitations

     

    For sponsorship opportunities please contact: sponsor@corvusglobalevents.com or call +44 (0) 207 096 0786

  • 10:30
  • Morning Coffee/Tea & Networking

  • 10:50
  • Medical Affairs and Clinical Operations collaborating on Clinical Trial Optimization


    Viraj Rajadhyaksha

    Viraj Rajadhyaksha Area Medical Director
    AstraZeneca

Patient Recruitment & Site Selection

  • 11:20
  • The National Institute for Health Research (NIHR) Patient Recruitment Centres: Optimising patient recruitment to ensure trial success


    Richard Evans

    Richard Evans Head Of Business Development and Innovation
    Leeds Teaching Hospitals NHS Trust

  • 11:40
  • Innovative analytic technologies for predictive modelling, forecasting and optimal designing patient recruitment in clinical trials

    • Advanced technologies to maximize patient recruitment predictability at different stages
    • Optimal time-cost efficient recruitment design, sites/countries selection
    • Data-driven re-projection and optimal adjustment of recruitment
    • Centralized statistical monitoring and detecting unusual data patterns
    • Predicting event counts in event-driven trials

    Vladimir Anisimov

    Vladimir Anisimov Principal Data Scientist, Data Science, Center for Design & Analysis
    Amgen

  • 12:00
  • Monitoring and Quality Assurance in site selection and patient recruitment to optimize clinical trials

    • Site pre-assessment and selection
    • Ensure patient protection and to deliver high quality data
    • Quality assurance can at times be difficult as regulatory requirements, standards and access to care differ globally – How are we going to handle this?

     

    For sponsorship opportunities please contact: sponsor@corvusglobalevents.com or call +44 (0) 207 096 0786

  • 12:20
  • Networking luncheons

  • 13:10
  • The Impact of Diversity Plans on Increasing Overall Enrollment in Clinical Trials


    Gayna B. Whitaker

    Gayna B. Whitaker President and Founder
    Genesis Medical Research Group

  • 13:40
  • Enrolment and retention in clinical studies before and during Covid-19 pandemic: clinical challenges and new opportunities. A case report from a phase 3 clinical program in fibromyalgia

    • What will persuade and impact the patient?
    • Is there anything pharma can provide for a trial member that will increase the value of participation?
    • The aim of patient-driven clinical trials is to diminish the burden of participation by making the participant journey as convenient and pleasant as possible
    • Utilize fitting procedures and techniques to limit dropouts without, in any capacity, constraining a patient to remain in the study

    Domenico Merante

    Domenico Merante Clinical Research Lead TA Orphan-Nephrology
    CSL Vifor

  • 14:10
  • Panel discussion: Critical Success Factors while Planning for Site Selection and Patient Recruitment

    • Discover sites with a demonstrated track record of good execution in trials
    • Study and site staff with solid certifications to expand the likelihood of powerful enrolment and an effective trial.
    • Factors such as disease prevalence rates, treatment practices, regulatory requirements and statistical considerations must be considered.
    • Access to subject population with the required eligibility criteria
    • Network within industries

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

    Diane Driver

    Diane Driver Head Program Delivery
    UCB

    Joanne Stevens

    Joanne Stevens Global Head of R&D Operations
    GE Healthcare

  • 14:40
  • How Can African Sites be routinely included? Addressing diversity at its core

    • Addressing and overcoming the fears
    • Understanding and removing the challenges
    • Providing robust tools to gather evidence
       

    Tina Barton

    Tina Barton Chief Operating Officer
    eMQT

    Shalom Lloyd

    Shalom Lloyd Co-Founder & Chief Strategy Officer
    eMQT

  • 15:10
  • Afternoon Tea/Coffee

Patient Centricity & Patient Engagement

  • 15:30
  • Patient Engagement in Clinical Development - A look at what the UK are doing to bring patients to the forefront of study design


    Alex Hammond

    Alex Hammond Business Development Manager
    NIHR Clinical Research Network

  • 16:00
  • EU-PEARL: An EU patient-centric clinical trial platform


    Nadir Ammour

    Nadir Ammour Global Lead, Clinical Innovation & External Partnership
    Sanofi

  • 16:30
  • Panel Discussion: Putting the patient first - Embedding a patient-centric approach to clinical trial design


    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

  • 17:00
  • Interactive Breakout Discussions

     

    All the participants will have a great opportunity to discuss and explore a selection of most interesting topics discussed during the conference in small groups with their industry colleagues in an informal setting.

    Round Table 1: Innovation in Clinical Trials - Digital Approaches

    Round Table 2: Patient Centricity

    Round Table 3: Globalization and Country Specifics

    Round Table 4: Recruitment Challenges - Patients and Sites

    Round Table 5: Changing Clinical Trials - What needs to be addressed

    Round Table 6: Patient Retention

  • 17:50
  • Chairperson’s closing remarks


    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

  • 18:00
  • Networking Drinks Session


Thursday - 11th May 2023

  • 08:30
  • Registration & Refreshments

  • 08:50
  • Chairperson’s opening remarks


    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

  • 09:00
  • EHR Case Study: NHS health records in pandemic vaccination programs


    Rebecca Jackson

    Rebecca Jackson Sr. Mgr. Clinical R&D Innovation & Novel Modalities IT
    The Janssen Pharmaceutical Companies of Johnson & Johnson

  • 09:30
  • Global Clinical Development – Complex Generics


    Siddharth Chachad

    Siddharth Chachad Executive Vice President & Head - Global Clinical Management
    Dr. Reddy's Laboratories

  • 09:50
  • Setting up Your Decentralised Trial for Success

     

    For sponsorship opportunities please contact: sponsor@corvusglobalevents.com or call +44 (0) 207 096 0786

Clinical Data & Tech Driven Clinical Trials

  • 10:10
  • How Real-World Evidence and Real World Data Can Help Regulatory Agencies Make More Informed Decisions


    Andrew Gray

    Andrew Gray Global Regulatory and R&D Policy
    Amgen

  • 10:30
  • Morning Coffee/Tea & Discussion

  • 10:50
  • Improving clinical data management (CDM) and statistics to meet new regulatory requirements

    • Integrating end-to-end clinical data management to manage data disruption
    • Centralized Statistical Monitoring to Improve the Quality of Clinical Data
    • Analysing the data constantly to evaluate and adjust the monitoring strategy as required

     

    For sponsorship opportunities please contact: sponsor@corvusglobalevents.com or call +44 (0) 207 096 0786

  • 11:10
  • Interpretation and Impact of Real-World Clinical Data

    • Strategies for better decision-making
    • High-level models and simulations compelled by data will allow elimination of risky trials
    • The potential of real world data in clinical research goes past patient identification and patient recruitment
       

    Mohamed Sharaf

    Mohamed Sharaf EMEA Senior Medical Advisor
    Janssen Europe, Middle East & Africa

  • 11:30
  • Trusting Digital Health Technologies: Why Global Standards Are A Must


    Maria Palombini

    Maria Palombini Leader, Healthcare Life Sciences Practice
    IEEE Standards Association

  • 12:00
  • Panel Discussion: The Evolution Of Tech- Enabled Clinical Trials and what to expect from the next decade of drug development

    • The use of artificial intelligence and machine learning
    • Effectively using Technology is enabling patient centricity
    • How to implement mobile technology and make it work in clinical trials
    • Does consumer technology devices used in clinical trials?
    • IoT in digital transformation of clinical trials
    • Technology partnerships

    Maria Palombini

    Maria Palombini Leader, Healthcare Life Sciences Practice
    IEEE Standards Association

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

  • 12:30
  • Networking luncheon

  • 13:10
  • Achieving a streamlined IRT development process

     

    IRT systems are critical to both randomisation and efficient drug supply management, but too often they are an afterthought for a study team juggling many conflicting priorities. With an efficient internal process, preferred IRT vendors and standardised IRT modules, processes and documentation, IRT development can be achieved in a streamlined fashion delivering an optimum IRT system with a fraction of the customary frustration and duplication of effort


    Kate Chapman

    Kate Chapman Director
    Clinical Technology Consultants Ltd

Outsourcing & Clinical Trials

  • 13:30
  • Weighing and evaluating the outsourcing approach that is right for you

    • Flexible, and easy to implement model
    • Creating an effective strategy to decide when to outsource
    • Analysing the key risk factors your CRO might bring and how to tackle them

  • 14:00
  • Key Considerations for Effective Clinical Trial Vendor Selection

    • Monitoring outsourced clinical trials
    • Managing Continuous & Real-Time Collaboration
    • Both sponsor and CRO must invest time in defining goals, anticipating issues and measuring results.

    Alpana Gandhi

    Alpana Gandhi Senior Process & Vendor Manager
    Boehringer Ingelheim

  • 14:20
  • How Industry Collaboration is Transforming Clinical Trials


    Sarah Tremethick

    Sarah Tremethick Global Consortia Program Lead - TransCelerate BioPharma Inc
    Roche

  • 14:50
  • A key factor in vendor Selection - The role of the CRO in advancing patientcentric clinical trial approaches

  • 15:20
  • Afternoon Tea/Coffee

Quality, Compliance & Risk Management

  • 15:40
  • Implementing risk proportionate approaches in clinical trials -moving towards risk-based monitoring

    • Observing exercises and methodologies ought to be chosen to be proportionate to the risks identified within a trial.
    • Risk-based monitoring needs an effective and adaptable technology platform with analytics, which are combined with monitoring to assess, manage and mitigate risk.

  • 16:00
  • Are we obsessed with Quality Tolerance Limits?

    • Choosing QTL Parameters wisely
    • Are you asking the right questions when considering the application of Quality Tolerance Limits (QTL)?
    • Controlling risk within diagnostic clinical studies

  • 16:30
  • Implementation of Quality by Design (QbD) Principles

  • 17:00
  • Panel Discussion – Partnering for progress - How Collaborative partnerships are transforming clinical trials?

    • Managing continuous & real-time collaboration
    • How transparency will lead to industrywide collaboration
    • Both sponsor and CRO must invest time in defining goals, anticipating issues and measuring results
    • Considering what patient centricity factors your CRO brings in

    Nancy Meyerson-Hess

    Nancy Meyerson-Hess Chief Compliance and Regulatory Officer
    eMQT

    Diane Driver

    Diane Driver Head Program Delivery
    UCB

  • 17:40
  • Chairperson’s closing remarks

BRING YOUR TEAM
Delegate Registration

Corvus Global Events recognises the value of learning in teams. There's so much great content!!!

Bring your team and get an extra discount. There are special group packages available. Please email to delegate@corvusglobalevents.comfor more details.

register now

PARTNERS

Partnerships typically involve an exchange of value and frequently include online content, PR, advertising, online & event branding.

For enquiries please e-mail to mediapartner@corvusglobalevents.com

VENUE

 

Holiday Inn London - Kensington
Wrights Lane, Kensington
London W8 5SP
United Kingdom


We make every effort to secure the very best hotel for our attendees with amazing event spaces, so that we’re able to guarantee our attendees the highest quality service and comfort.

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now